Current status: Answered by Jenni Minto on 24 January 2025
To ask the Scottish Government what areas of brain cancer research it allocated funding to in 2023-24, also broken down by the amount allocated to each area.
Within the Scottish Government, funding of Health and Care Research comes under the remit of the Chief Scientist Office (CSO).
CSO funds research projects via its Translational Clinical Studies (TCS) Committee and the Health Improvement, Protection and Services Research (HIPS) Committee
https://www.cso.scot.nhs.uk/grant-funding/response-mode-funding-schemes/
CSO funds capacity building research via its Fellowship Funding programmes
https://www.cso.scot.nhs.uk/fellowship-funding/
Research funding is not allocated to any particular condition and CSO funds research across the clinical spectrum. All applications go through a process of independent expert review to allow funding decisions to be made. Applications on Brain Tumours are welcomed and CSO's role is well known across the Health and Care research community in Scotland
In 2023-24 the following funding was awarded specifically for research in Brain Cancer
TCS/23/18 - Assessment of Brain Tumours with Dynamic T2* and Lactate MR under Oxygen Challenge to Evaluate Aerobic and Anaerobic Metabolic Status of Gliomas
£299,918
Tessa Jowell Fellowship in Neuro-oncology
£44,237
In addition, CSO provides infrastructure funding to support the delivery of clinical studies in the NHS in Scotland. In 2023-24 the cancer-specific component of this infrastructure funding was £1,112,434. This figure includes funding for the NHS Research Scotland Cancer Research Network and the CSO component of funding for the Experimental Cancer Medicine Centres in Edinburgh and Glasgow (co-funded 50:50 with Cancer Research UK). The purpose of this funding is to support the delivery of early and later phase cancer clinical studies, including in Brain Tumours.